Carolyn F. Deacon

Carolyn F. Deacon

Associate Professor


  1. 2011
  2. Published

    Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on incretin hormones. / Olthof, MR; van Dijk, AE; Deacon, Carolyn F.; Heine, RJ; van Dam, RM .

    In: Nutrition & Metabolism, Vol. 8, 2011, p. Artikel 10.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Dipeptidyl peptidase-4 inhibition increases portal concentrations of intact glucagon-like peptide-1 (GLP-1) to a greater extent than peripheral concentrations in anaesthetised pigs. / Hjøllund, K R; Deacon, C F; Holst, Jens Juul.

    In: Diabetologia, Vol. 54, No. 8, 2011, p. 2206-8.

    Research output: Contribution to journalLetterResearchpeer-review

  4. Published

    Effects of saxagliptin on β-cell stimulation and insulin secretion in patients with type 2 diabetes. / Henry, R R; Smith, Susanne; Schwartz, Saul; Mudaliar, S R; Deacon, C F; Holst, Jens Juul; Duan, R Y; Chen, R S; List, J F.

    In: Diabetes, Obesity and Metabolism, Vol. 13, No. 9, 2011, p. 850-858.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    GIP does not potentiate the antidiabetic effects of GLP-1 in hyperglycemic patients with type 2 diabetes. / Mentis, Nikolaos; Vardarli, Irfan; Köthe, Lars D; Holst, Jens Juul; Deacon, Carolyn F; Theodorakis, Michael; Meier, Juris J; Nauck, Michael A.

    In: Diabetes, Vol. 60, No. 4, 2011, p. 1270-1276.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Incretin-based therapies– review of the physiology, pharmacology and emerging clinical experience. / Martin, JH; Deacon, Carolyn F.; Gorrell, MD; Prins, JB.

    In: Internal Medicine Journal (Online), Vol. 41, 2011, p. 299-307.

    Research output: Contribution to journalReviewResearchpeer-review

  7. Published

    Inhibition of DPP-4 with vildagliptin improved insulin secretion in response to oral as well as "isoglycemic" intravenous glucose without numerically changing the incretin effect in patients with type 2 diabetes. / Vardarli, Irfan; Nauck, Michael A; Köthe, Lars D; Deacon, Carolyn F; Holst, Jens Juul; Schweizer, Anja; Foley, James E.

    In: Journal of Clinical Endocrinology and Metabolism, Vol. 96, No. 4, 2011, p. 945-954.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Physiology of incretins in health and disease. / Deacon, Carolyn F.; Ahren, Bo.

    In: Review of Diabetic Studies, Vol. 8, No. 3, 2011, p. 293-306.

    Research output: Contribution to journalReviewResearchpeer-review

  9. Published

    Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes : what is up, what is down? / Nauck, M A; Vardarli, I; Deacon, C F; Holst, Jens Juul; Meier, Joachim.

    In: Diabetologia, Vol. 54, No. 1, 2011, p. 10-18.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: A comparative review. / Deacon, Carolyn F.

    In: Diabetes, Obesity and Metabolism, Vol. 13, No. 1, 01.2011, p. 7-18.

    Research output: Contribution to journalReviewResearchpeer-review

  11. Published
Previous 1 2 Next

ID: 9220